Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 74,784 shares, a drop of 50.6% from the December 31st total of 151,372 shares. Based on an average trading volume of 780,682 shares, the short-interest ratio is currently 0.1 days. Approximately 103.9% of the company’s shares are sold short. Approximately 103.9% of the company’s shares are sold short. Based on an average trading volume of 780,682 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
AKAN has been the subject of a number of research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Akanda in a research report on Monday, January 12th. Wall Street Zen raised Akanda to a “sell” rating in a research note on Saturday, October 18th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.
Check Out Our Latest Report on Akanda
Akanda Price Performance
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Featured Stories
- Five stocks we like better than Akanda
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- The biggest scam in the history of gold markets is unwinding
- Buy This Stock at 9:30 AM on MONDAY!
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
